Evidence map›Paper›PMID 37506496›Full record

ArticleVision research2023

Eye movements in visual impairment.

Preeti Verghese, Marcus Nyström, Tom Foulsham, Paul V McGraw

Open access · greenAbstract readEditorial
In one paragraph

Article in Vision research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Preeti VergheseSmith-Kettlewell Eye Research Institute, San Francisco, CA, USA. Electronic address: preeti@ski.org.
Marcus NyströmLund University Humanities Lab, Lund, Sweden.
Tom FoulshamDepartment of Psychology, University of Essex, Wivenhoe Park, Colchester, UK.
Paul V McGrawVisual Neuroscience Group, School of Psychology, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Lund University · SESmith-Kettlewell Eye Research Institute · USUniversity of Essex · GBUniversity of Nottingham · GB

Funding

Maximizing Visual Potential in Age-Related Macular DegenerationR01EY027390 · NEI · SMITH-KETTLEWELL EYE RESEARCH INSTITUTE · PI Preeti Verghese · 2017 to 2026
$5.7M
Stereopsis and Suppression in Strabismus and AmblyopiaR01EY034370 · NEI · SMITH-KETTLEWELL EYE RESEARCH INSTITUTE · PI VERGHESE, PREETI · 2022 to 2025
$1.6M
NEI NIH HHS R01 EY027390NEI NIH HHS R01 EY034370
6 · The paper itself

Abstract

This Special Issue describes the impact of visual impairment on visuomotor function. It includes contributions that examine gaze control in conditions associated with abnormal visual development such as amblyopia, dyslexia and neurofibromatosis as well as disorders associated with field loss later in life, such as macular degeneration and stroke. Specifically, the papers address both gaze holding (fixation), and gaze-following behavior (single saccades, sequences of saccades and smooth-pursuit) that characterize active vision in daily life and evaluate the influence of both pathological and simulated field loss. Several papers address the challenges to reading and visual search; describing how the patterns of eye movements in these real-world tasks adapt to visual impairment and highlighting how they could serve as diagnostic markers of visuomotor function.

Indexed as

AmblyopiaVision, LowEye MovementsHumansPursuit, SmoothSaccadesVision, OcularAmblyopiaCentral field lossDyslexiaFixationHemianopiaMacular degenerationNeurofibromatosisReadingSaccadesSimulated vision lossSmooth pursuitVisual search

Identifiers

PMID37506496
PMCPMC10529007
OpenAlexW4385377532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.